Tipsheet
What matters at India’s listed companies
Earnings · Packaging · Small cap

Uflex posts best margin in 14 quarters after Q4 EBITDA surges 32%

A broad-based recovery in packaging and films drove Q4 EBITDA to ₹6,265 million, pushing margins to 15.3%. Full-year revenue growth remained flat at 2.1%.


Mkt cap₹3,039 cr
P/E20.53×
ROE1.93%
Debt / eq.1.10
Div yld0.70%
15.3% Q4 EBITDA margin, highest in 14 quarters.

What's new

  • Q4 consolidated revenue rose 5.7% YoY to ₹40,973 million.
  • Q4 EBITDA jumped 31.8% to ₹6,265 million, with margin hitting 15.3%.
  • Full-year revenue grew 2.1% to ₹155,130 million.

Why this matters

The 31.8% EBITDA jump on modest 5.7% revenue growth signals a meaningful shift in product mix or cost structure. Hitting a 14-quarter margin high is a real operational improvement. The Egypt and Mexico projects must now build on that efficiency without diluting it.

What we're watching

  • Whether the 15.3% margin holds as new Egypt and Mexico capacity ramps in FY27.
  • How West Asia conflict disruptions affect the timeline and cost of new international projects.
  • If the Q4 strength was a one-off recovery or the start of a sustained profitability trend.

The full read

Uflex finished FY26 with its strongest quarter in over three years. Q4 EBITDA jumped 31.8% to ₹6,265 million on a 5.7% revenue rise to ₹40,973 million. The margin of 15.3% is the highest in 14 quarters. Full-year revenue growth of just 2.1% to ₹155,130 million was modest, making the Q4 surge look like a sharp recovery rather than a steady climb. Management pointed to better product mix and higher capacity utilization. The next phase is execution: a 12-billion unit aseptic plant in Egypt and a WPP bag facility in Mexico are both slated for H1 FY27 commissioning. The challenge is holding the new margin discipline while integrating international capacity against a backdrop of conflict and tariff noise. The 14-quarter high is a good starting point, but the annual numbers show how far the company has to go to make it stick.

Questions answered

What drove the sharp EBITDA increase in Q4 despite modest revenue growth?
Management cited a broad-based recovery across packaging and films segments, allowing EBITDA to jump 31.8% while revenue grew only 5.7%. This pushed margins to 15.3%, the highest in 14 quarters.
How did full-year results compare to the strong Q4 finish?
Full-year revenue grew just 2.1% to ₹155,130 million. The strong Q4 finish lifted the annual numbers, indicating most of the growth was concentrated in the final quarter.
What are the key capacity expansion projects underway?
Uflex is building a 12-billion-unit aseptic packaging facility in Egypt and a WPP bag plant in Mexico. Both are expected to be commissioned in the first half of FY27.
What operational headwinds did management acknowledge?
Management noted ongoing supply chain disruptions from the West Asia conflict and broader tariff uncertainty as factors affecting operations, despite the strong quarterly finish.
Mentioned: ₹40,973 million Q4 revenue · ₹155,130 million FY26 revenue · 12-billion aseptic plant in Egypt
Primary source BSE · NSE

An independent reading of the company's own disclosure — the primary filing above is the final word.